Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMP-activated protein kinase catalytic subunit alpha (AMPK-α) is the enzymatic component of the heterotrimeric AMPK complex, which serves as a master regulator of cellular and whole-body energy homeostasis [1, 6]. It functions as a metabolic sensor that is activated in response to energy stress, characterized by an increase in the AMP/ATP or ADP/ATP ratio [4, 10]. Once activated, AMPK-α phosphorylates a wide array of downstream targets to inhibit energy-consuming anabolic processes, such as lipid and protein synthesis, while stimulating energy-producing catabolic pathways like fatty acid oxidation and glucose uptake [8, 14]. This makes it a primary therapeutic target for metabolic disorders, including type 2 diabetes and obesity, where it helps restore insulin sensitivity and glucose balance [3, 12]. Beyond its metabolic roles, AMPK-α is involved in regulating autophagy, cell growth through the inhibition of the mTORC1 pathway, and inflammatory responses [1, 15]. Pharmacological modulation includes indirect activators like metformin and direct small-molecule activators such as MK-8722 [14, 15]. However, therapeutic development faces challenges such as potential cardiac hypertrophy and the complex, context-dependent role of AMPK in cancer progression [15].
Activation of the catalytic subunit through allosteric binding of AMP/ADP or direct small-molecule activators, leading to phosphorylation of downstream metabolic and growth-regulating substrates.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMP-activated protein kinase catalytic subunit alpha (AMPK-α) (AMPK-α).